Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,966,085
+$4,677,185 QoQ
Shares Held
235,163
+312.3% QoQ
Ownership
0.590%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 254 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Derivatives in PCRX
reported options exposure · as of Jun 30, 2025CallValue
$4,309,170
CallShares
180,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. PCRX ranks #21 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
409,074 | $221,648,565 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,853,212 | $179,212,890 | |
| 3 | ZTS |
Zoetis Inc.
|
1,813,759 | $130,336,721 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,265,321 | $110,629,075 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,098,945 | $86,119,713 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,725,889 | $67,084,128 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
507,207 | $41,986,595 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
336,399 | $37,320,105 |
All Filings in PCRX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,966,085 | 235,163 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,288,900 | 57,031 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,173,043 | 122,606 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,823,433 | 70,758 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,309,073 | 515,024 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $4,309,170 | 180,300 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $8,588,781 | 345,625 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,262,148 | 544,700 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $27,987,046 | 1,485,512 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,120,886 | 606,039 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $715,250 | 25,000 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $1,094,230 | 37,448 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $1,531,576 | 49,921 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $311,504 | 7,774 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $457,072 | 11,200 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $64,754,981 | 1,586,743 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $44,469,221 | 1,151,754 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,896,856 | 468,074 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,829,162 | 31,375 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $7,971,502 | 132,483 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,854,032 | 68,822 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,955,579 | 147,587 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,014,090 | 114,340 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,145,282 | 85,984 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,049,418 | 83,989 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $206,207 | 3,930 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,648,262 | 168,454 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||